Saturday 17 October 2026 Export TVRD’s income statement to Excel — free account

Tvardi Therapeutics, Inc.

In the quarter to June 2026, revenue grew 20.3%, EPS fell 235.3% and free cash flow fell 57.3%, each against the same quarter a year earlier.

1.01 0.06 −5.61%

Follow TVRD

Alert me

Market cap: $14.3M
P/E: 0.0×
Fwd P/E: −0.5×
Dividend yield: —
F-score: 3/9
Altman Z: −5.15
Beneish M: −3.66
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(126.19%)	(480.07%)	51.90%	19.93%	+8 more TTM periods Free account
ROA Full definition →	(85.08%)	(47.68%)	(54.15%)	6.30%
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(326.11%)	(109.40%)	(88.64%)	10.37%
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(2.67)	(2.31)	(3.17)	(2.42)
Free Cash Flow Full definition →	(25.03)	(21.67)	(23.50)	(22.65)
Other line items
Cash ROIC Full definition →	(103.65%)	(54.88%)	(45.40%)	(35.21%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	(0.43)	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.96	1.40	1.29	(7.95)
Depreciation/Fixed assets Full definition →	(2.92)	(2.39)	(2.02)	1.58
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(2.67)	(2.31)	(3.17)	(2.42)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly